Wikidata

(Q35789894)

English

Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development

scientific article published on June 2004

In more languages

Statements

title
Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15173098
retrieved
10 August 2017
main subject
biomarker
0 references
author name string
John W Park
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15173098
retrieved
10 August 2017
Robert S Kerbel
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15173098
retrieved
10 August 2017
Gary J Kelloff
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15173098
retrieved
10 August 2017
J Carl Barrett
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15173098
retrieved
10 August 2017
Bruce A Chabner
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15173098
retrieved
10 August 2017
David R Parkinson
series ordinal
6
1 reference
stated in
Europe PubMed Central
PubMed ID
15173098
retrieved
10 August 2017
Jonathan Peck
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
15173098
retrieved
10 August 2017
Raymond W Ruddon
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
15173098
retrieved
10 August 2017
Caroline C Sigman
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
15173098
retrieved
10 August 2017
Dennis J Slamon
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
15173098
retrieved
10 August 2017
page(s)
3885-3896
1 reference
stated in
Europe PubMed Central
PubMed ID
15173098
retrieved
10 August 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q35789894&oldid=1586173874"